Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Independent Investigator Grant Study-Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism

NCT00287820 is registered in ClinicalTrials.gov with Nathan Kline Institute for Psychiatric Research as lead sponsor.

NCT NCT00287820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00287820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Independent Investigator Grant Study-Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
Lead sponsor
Nathan Kline Institute for Psychiatric Research
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2004
Completion date
September 30, 2007
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hyperglycemia, metabolic syndrome, schizophrenia